What Most Often Delays Clinical Trial Timelines?

Despite advances in trial design, digital tools and operational models, delays remain a persistent challenge in clinical research. From complex protocols and lengthy site activation processes to recruitment hurdles and downstream data management, multiple factors can extend clinical trial timelines and increase development costs.

As sponsors, CROs and sites work to accelerate study execution without compromising quality or compliance, understanding the primary sources of delay is critical. What do you think most slows down clinical trial timelines today? Cast your vote below and join the conversation.

Related: What Is the Biggest Barrier to Patient Participation in Clinical Trials?